PCG
MNTA

Private Capital Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Private Capital Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed – – 2182
2020
Q3 		$0 Hold
3
– – ﹤0.01% 2163
2020
Q2 		$0 Hold
3
– – ﹤0.01% 2196
2020
Q1 		$0 Sell
3
-70
-96% -$1.95K ﹤0.01% 2215
2019
Q4 		$1K Buy
73
+29
+66% +$464 ﹤0.01% 1911
2019
Q3 		$1K Buy
+44
New +$531 ﹤0.01% 2149

Private Capital Group's MNTA Position: Q4 2020 in Review

Private Capital Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 3 shares.

Private Capital Group first reported a position in MNTA in Q3 2019 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Private Capital Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Private Capital Group sold 3 Momenta Pharmaceuticals, Inc. shares in Q4 2020.
  • Private Capital Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2019 and held it in 5 quarters.
  • Private Capital Group's Momenta Pharmaceuticals, Inc. position peaked at $1K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Private Capital Group's 13F filing for Q4 2020, filed 26 Jan 2021.